MoonLake Immunotherapeutics (MLTX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $9.55, -6.92% vs the prior close of $10.26.
- Volume 1.38M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MLTX slides 6.9% to $9.55, a 6-month low. Closed at $9.55, -6.92% vs the prior close of $10.26. Day range $9.46–$10.34, opened at $10.34.
MLTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MLTX slides 6.9% to $9.55, a 6-month low
- Closed at $9.55, -6.92% vs the prior close of $10.26. Day range $9.46–$10.34, opened at $10.34.
- Volume was 1.38M shares, 0.8x its 50-day average of 1.68M.
- Price is -29.6% vs its 50-day average ($13.57) and -42.5% vs its 200-day average ($16.61).
- 52-week range $8.80–$23.29; today's close sits at 5% of that range, 59.0% below the 52-week high.
Oct 15, 2026 — MLTX rises 1.2% to $10.26
- Closed at $10.26, +1.18% vs the prior close of $10.14. Day range $10.14–$10.51, opened at $10.16.
- Volume was 1.07M shares, 0.6x its 50-day average of 1.67M.
- Price is -25.3% vs its 50-day average ($13.74) and -38.3% vs its 200-day average ($16.63).
- 52-week range $8.80–$23.29; today's close sits at 10% of that range, 55.9% below the 52-week high.
Oct 14, 2026 — MLTX dips 2.6% to $10.14, a 6-month low, 3 down days in a row
- Closed at $10.14, -2.59% vs the prior close of $10.41. Day range $10.01–$10.65, opened at $10.30.
- Volume was 1.77M shares, 1.1x its 50-day average of 1.65M.
- Price is -27.0% vs its 50-day average ($13.89) and -39.1% vs its 200-day average ($16.64).
- 52-week range $8.80–$23.29; today's close sits at 9% of that range, 56.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — MLTX dips 2.5% to $10.41, a 6-month low
- Closed at $10.41, -2.53% vs the prior close of $10.68. Day range $10.35–$10.84, opened at $10.70.
- Volume was 2.41M shares, 1.5x its 50-day average of 1.63M.
- Price is -25.9% vs its 50-day average ($14.04) and -37.5% vs its 200-day average ($16.66).
- 52-week range $8.80–$23.29; today's close sits at 11% of that range, 55.3% below the 52-week high.
Oct 12, 2026 — MLTX dips 1.3% to $10.68
- Closed at $10.68, -1.29% vs the prior close of $10.82. Day range $10.66–$11.00, opened at $10.82.
- Volume was 1.21M shares, 0.7x its 50-day average of 1.62M.
- Price is -24.7% vs its 50-day average ($14.18) and -36.0% vs its 200-day average ($16.68).
- 52-week range $8.80–$23.29; today's close sits at 13% of that range, 54.1% below the 52-week high.
Oct 9, 2026 — MLTX rises 2.3% to $10.82
- Closed at $10.82, +2.27% vs the prior close of $10.58. Day range $10.40–$11.09, opened at $10.58.
- Volume was 2.01M shares, 1.3x its 50-day average of 1.59M.
- Price is -24.5% vs its 50-day average ($14.34) and -35.2% vs its 200-day average ($16.70).
- 52-week range $8.80–$23.29; today's close sits at 14% of that range, 53.5% below the 52-week high.
Oct 8, 2026 — MLTX dips 1.8% to $10.58, a 6-month low on 2.4x normal volume
- Closed at $10.58, -1.76% vs the prior close of $10.77. Day range $10.00–$10.80, opened at $10.75.
- Volume was 3.72M shares, 2.4x its 50-day average of 1.53M — unusually heavy trading.
- Price is -27.0% vs its 50-day average ($14.50) and -36.7% vs its 200-day average ($16.71).
- 52-week range $8.80–$23.29; today's close sits at 12% of that range, 54.6% below the 52-week high.
- That makes 6 straight losses.
Oct 7, 2026 — MLTX dips 1.6% to $10.77, a 6-month low, 5 down days in a row
- Closed at $10.77, -1.64% vs the prior close of $10.95. Day range $10.71–$11.29, opened at $10.81.
- Volume was 1.40M shares, 0.9x its 50-day average of 1.53M.
- Price is -26.5% vs its 50-day average ($14.66) and -35.6% vs its 200-day average ($16.72).
- 52-week range $8.18–$23.29; today's close sits at 17% of that range, 53.8% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — MLTX slides 3.8% to $10.95, a 6-month low on 2.1x normal volume
- Closed at $10.95, -3.78% vs the prior close of $11.38. Day range $10.91–$11.50, opened at $11.50.
- Volume was 3.05M shares, 2.1x its 50-day average of 1.48M — unusually heavy trading.
- Price is -26.1% vs its 50-day average ($14.81) and -34.6% vs its 200-day average ($16.74).
- 52-week range $8.18–$23.29; today's close sits at 18% of that range, 53.0% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — MLTX ends flat (-0.3%) to $11.38, a 6-month low, 3 down days in a row
- Closed at $11.38, -0.26% vs the prior close of $11.41. Day range $11.19–$11.72, opened at $11.56.
- Volume was 1.87M shares, 1.3x its 50-day average of 1.46M.
- Price is -24.1% vs its 50-day average ($14.99) and -32.1% vs its 200-day average ($16.75).
- 52-week range $7.50–$23.29; today's close sits at 25% of that range, 51.1% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — MLTX dips 0.5% to $11.41, a 6-month low
- Closed at $11.41, -0.52% vs the prior close of $11.47. Day range $11.03–$11.65, opened at $11.64.
- Volume was 1.83M shares, 1.3x its 50-day average of 1.44M.
- Price is -24.7% vs its 50-day average ($15.15) and -32.0% vs its 200-day average ($16.77).
- 52-week range $6.56–$23.29; today's close sits at 29% of that range, 51.0% below the 52-week high.
MLTX latest news & SEC filings
Every SEC filing by or about MLTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 10, 2026 · Form S-3ASR — S-3ASR filing
S-3ASR filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$61.80M (prior year -$55.22M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.84 (prior year -$0.87) (loss narrowed vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Reich Kristian sold 1,100 shares at $20.00 (≈$22.00K) on Jul 27, 2026
- Reich Kristian sold 1,100 shares at $20.00 (≈$22.00K) on Jul 27, 2026
- Reich Kristian sold 1,100 shares at $20.00 (≈$22.00K) on Jul 27, 2026
- Reich Kristian sold 1,100 shares at $20.00 (≈$22.00K) on Jul 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Reich Kristian sold 2,448 shares at $20.00 (≈$48.96K) on Jul 22, 2026
- Reich Kristian sold 2,448 shares at $20.00 (≈$48.96K) on Jul 22, 2026
- Reich Kristian sold 2,448 shares at $20.00 (≈$48.96K) on Jul 22, 2026
- Reich Kristian sold 2,448 shares at $20.00 (≈$48.96K) on Jul 22, 2026
- Reich Kristian sold 50,000 shares at $20.02 (≈$1.00M) on Jul 21, 2026
- Reich Kristian sold 50,000 shares at $20.02 (≈$1.00M) on Jul 21, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Reich Kristian sold 43,700 shares at $20.09 (≈$877.93K) on Jul 20, 2026
- Reich Kristian sold 43,700 shares at $20.09 (≈$877.93K) on Jul 20, 2026
- Reich Kristian sold 43,700 shares at $20.09 (≈$877.93K) on Jul 20, 2026
- Reich Kristian sold 43,700 shares at $20.09 (≈$877.93K) on Jul 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 20, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Reich Kristian sold 16,105 shares at $20.01 (≈$322.26K) on Jul 15, 2026
- Reich Kristian sold 16,105 shares at $20.01 (≈$322.26K) on Jul 15, 2026
- Reich Kristian sold 16,105 shares at $20.01 (≈$322.26K) on Jul 15, 2026
- Reich Kristian sold 16,105 shares at $20.01 (≈$322.26K) on Jul 15, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 15, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Santos Da Silva Jorge sold 68,289 shares at $20.02 (≈$1.37M) on Jul 10, 2026
- Santos Da Silva Jorge sold 68,289 shares at $20.02 (≈$1.37M) on Jul 10, 2026
- Santos Da Silva Jorge sold 68,289 shares at $20.02 (≈$1.37M) on Jul 10, 2026
- Santos Da Silva Jorge sold 68,289 shares at $20.02 (≈$1.37M) on Jul 10, 2026
- Santos Da Silva Jorge sold 33,936 shares at $20.01 (≈$679.06K) on Jul 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade MLTX
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Feb 23, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.60% (largest 6.9%).
- Liquidity: about 1.89M shares (≈$18.07M) trade per day on average.
- 52-week position: $9.55 vs a range of $8.80–$23.29 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Kristian Reich sold 1,100 shares on Jul 27, 2026.
- Latest filings: 8-K Sep 30, 2026; 10-Q Aug 10, 2026; 8-K Aug 10, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MLTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.34 | 10.34 | 9.46 | 9.55 | 1.38M |
| Oct 15, 2026 | 10.16 | 10.51 | 10.14 | 10.26 | 1.07M |
| Oct 14, 2026 | 10.30 | 10.65 | 10.01 | 10.14 | 1.77M |
| Oct 13, 2026 | 10.70 | 10.84 | 10.35 | 10.41 | 2.41M |
| Oct 12, 2026 | 10.82 | 11.00 | 10.66 | 10.68 | 1.21M |
| Oct 9, 2026 | 10.58 | 11.09 | 10.40 | 10.82 | 2.01M |
| Oct 8, 2026 | 10.75 | 10.80 | 10.00 | 10.58 | 3.72M |
| Oct 7, 2026 | 10.81 | 11.29 | 10.71 | 10.77 | 1.40M |
| Oct 6, 2026 | 11.50 | 11.50 | 10.91 | 10.95 | 3.05M |
| Oct 5, 2026 | 11.56 | 11.72 | 11.19 | 11.38 | 1.87M |
| Oct 2, 2026 | 11.64 | 11.65 | 11.03 | 11.41 | 1.83M |
| Oct 1, 2026 | 11.73 | 11.84 | 11.29 | 11.47 | 1.31M |
| Sep 30, 2026 | 11.52 | 12.00 | 11.39 | 11.70 | 1.99M |
| Sep 29, 2026 | 11.56 | 11.70 | 11.40 | 11.45 | 1.51M |
| Sep 28, 2026 | 12.04 | 12.04 | 11.53 | 11.56 | 1.66M |
| Sep 25, 2026 | 12.15 | 12.20 | 11.80 | 12.04 | 2.18M |
| Sep 24, 2026 | 12.69 | 12.83 | 12.04 | 12.12 | 1.90M |
| Sep 23, 2026 | 13.41 | 13.69 | 12.23 | 12.90 | 2.00M |
| Sep 22, 2026 | 12.73 | 13.44 | 12.54 | 13.38 | 2.36M |
| Sep 21, 2026 | 12.50 | 12.65 | 12.24 | 12.55 | 1.22M |
About MoonLake Immunotherapeutics
MoonLake Immunotherapeutics (MLTX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ZUG, Switzerland. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1821586.
MLTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Value Fund Ii Lp Biotechnology | See Explanation of Responses | Jun 22, 2026 |
| Value Fund L P Biotechnology | Director | Jun 22, 2026 |
| Gp Holdings Llc Bvf | Director | Jun 22, 2026 |
| I Gp Llc Bvf | Director | Jun 22, 2026 |
| Ii Gp Llc Bvf | See Explanation of Responses | Jun 22, 2026 |
| Inc/Il Bvf | Director | Jun 22, 2026 |
| Partners L P/Il Bvf | Director | Jun 22, 2026 |
| Partners Os Ltd. Bvf | See Explanation of Responses | Jun 22, 2026 |
| Value Trading Fund Os Lp Biotechnology | See Explanation of Responses | Jun 22, 2026 |
| Mark N Lampert | Director | Jun 22, 2026 |
| Spike Loy | Director | Jun 18, 2026 |
| Catherine Moukheibir | Director | Jun 18, 2026 |
| Andrew John Phillips | Director | Jun 18, 2026 |
| Da Silva Jorge Santos | Chief Executive Officer | Jul 13, 2026 |
| Ramnik Xavier | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Matthias Bodenstedt | Chief Financial Officer | Jun 23, 2026 |
| Kristian Reich | Chief Scientific Officer | Jul 29, 2026 |
| Da Silva Jorge Santos | Chief Executive Officer | Jul 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 27, 2026 | Kristian Reich | Sale | 1,100 | $20.00 |
| Jul 27, 2026 | Kristian Reich | Sale | 1,100 | $20.00 |
| Jul 27, 2026 | Kristian Reich | Sale | 1,100 | $20.00 |
| Jul 27, 2026 | Kristian Reich | Sale | 1,100 | $20.00 |
| Jul 22, 2026 | Kristian Reich | Sale | 2,448 | $20.00 |
| Jul 22, 2026 | Kristian Reich | Sale | 2,448 | $20.00 |
| Jul 22, 2026 | Kristian Reich | Sale | 2,448 | $20.00 |
| Jul 22, 2026 | Kristian Reich | Sale | 2,448 | $20.00 |
| Jul 21, 2026 | Kristian Reich | Sale | 50,000 | $20.02 |
| Jul 21, 2026 | Kristian Reich | Sale | 50,000 | $20.02 |
| Jul 21, 2026 | Kristian Reich | Sale | 50,000 | $20.02 |
| Jul 21, 2026 | Kristian Reich | Sale | 50,000 | $20.02 |
| Jul 20, 2026 | Kristian Reich | Sale | 43,700 | $20.09 |
| Jul 20, 2026 | Kristian Reich | Sale | 43,700 | $20.09 |
| Jul 20, 2026 | Kristian Reich | Sale | 43,700 | $20.09 |
MLTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-227.32M | -3.53 | $-196.01M |
| Dec 31, 2024 | — | $-118.94M | -1.89 | $-116.59M |
| Dec 31, 2023 | — | $-36.01M | -0.73 | $-42.78M |
| Dec 31, 2022 | — | $-49.97M | -1.70 | $-55.89M |
| Dec 31, 2021 | — | $-4.54M | — | $-611.07K |
Latest balance sheet: total assets $573.95M, total liabilities $145.75M, cash $477.90M (as of Jun 30, 2026).
MLTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $17.33 |
| May 11, 2026 | 8-K Item 2.02 (results) | $18.84 |
| Feb 23, 2026 | 8-K Item 2.02 (results) | $18.68 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $10.59 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $53.41 |
| May 12, 2025 | 8-K Item 2.02 (results) | $40.18 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $42.37 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $50.67 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MLTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.